TrianglePUBLICATIONS · 35339649
Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2022 Jul
- First author
- Zer A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Zer A
- type
- Author
- name
- Icht O
- type
- Author
- name
- Yosef L
- type
- Author
- name
- Avram D
- type
- Author
- name
- Jacobi O
- type
- Author
- name
- Fenig E
- type
- Author
- name
- Kurman N
- type
- Author
- name
- Peretz I
- type
- Author
- name
- Shamai S
- type
- Author
- name
- Merimsky O
- type
- Author
- name
- Ben-Ami E
- type
- Author
- name
- Shapira Frommer R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Zer A
- type
- Author
- name
- Icht O
- type
- Author
- name
- Yosef L
- type
- Author
- name
- Avram D
- type
- Author
- name
- Jacobi O
- type
- Author
- name
- Fenig E
- type
- Author
- name
- Kurman N
- type
- Author
- name
- Peretz I
- type
- Author
- name
- Shamai S
- type
- Author
- name
- Merimsky O
- type
- Author
- name
- Ben-Ami E
- type
- Author
- name
- Shapira Frommer R
- type
- Author
- bibliography ids
- nci-bib-e6237969119d2380b2c93d29
- book metadata
- content sha256
- 45eacdf92b0e8cff85757cb65ec018fdbfb2c74c77780d9d8e6d463b71737606
- document type
- citation
- dois
- 10.1016/j.annonc.2022.03.012
- electronic publication date
- display
- 2022 Mar 23
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35339649
- immutable id
- pubmed:35339649@45eacdf92b0e8cff85757cb65ec018fdbfb2c74c77780d9d8e6d463b71737606
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 7
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 720-727
- volume
- 33
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35339649
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- 40827355e90986b7f690ee797ac76b5b17be9d0238b0878bb9d47af44addcfe9
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Jul
- precision
- month
- year
- 2022
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).
Preserved source evidence · Not medical advice